URISPAS SKF (Urispas 100 mg)
Generic Name: flavoxate
Pill with imprint URISPAS SKF is White, Round and has been identified as Urispas 100 mg. It is supplied by GlaxoSmithKline.
Urispas is used in the treatment of overactive bladder; dysuria; urinary incontinence and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Urispas 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for URISPAS SKF
Urispas
- Generic Name:
- flavoxate
- Imprint:
- URISPAS SKF
- Strength:
- 100 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-5290
More about Urispas (flavoxate)
- Urispas Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 2 Reviews – Add your own review/rating
- Drug class: urinary antispasmodics
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
